 | | | | Authorities in the Democratic Republic of Congo have confirmed a new case of Ebola in the remote, militia-controlled territory of Walikale, hundreds of kilometers away from where previous cases near the border with Uganda and Rwanda occurred, the Health Ministry said overnight. | | | | | | The Philippines has set up a crisis management team to determine if the deadly African swine fever virus has reached the country after officials detected a rise in pig deaths in some areas. | | | | | | The U.S. Centers for Disease Control and Prevention is investigating a "cluster" of lung illnesses that it believes may be linked to e-cigarette use after such cases were reported in 14 states. | | | | | | An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug Administration (FDA) announced data from tests of its gene therapy Zolgensma had been manipulated. | | | | | | High levels of E.coli bacteria forced Tokyo officials to cancel the swimming segment of Saturday's Paratriathlon World Cup, raising concerns about next year's Summer Olympic and Paralympic Games. | | | | | | Increasing numbers of middle-aged Americans appear to be developing cancers that can be associated with obesity, new data suggest. | | | | | | AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on Friday, a big boost for the drugmaker struggling with rising competition for Humira, its blockbuster therapy for the same condition. | | | | | | Roche Holding AG has priced its personalized cancer treatment, Rozlytrek, at about $17,050 per month, nearly half of the monthly price of a rival drug from Bayer AG and Eli Lilly and Co that was approved last year. | | | | | | Court-ordered anti-smoking ads sponsored by the tobacco industry reached only around 40% of adults and about half of all smokers in the U.S., a recent study suggests. | | | | | | Hospital workers often come to work with contagious respiratory illnesses, against the recommendations of public health regulators, a Canadian study suggests. | | | | | | The U.S. Food and Drug Administration on Friday approved Celgene Corp's Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved drug to treat the disease. | | | | | |
